mk-7655 and Acute-Kidney-Injury

mk-7655 has been researched along with Acute-Kidney-Injury* in 1 studies

Other Studies

1 other study(ies) available for mk-7655 and Acute-Kidney-Injury

Article	Year
Alteration in Acute Kidney Injury Potential with the Combination of Vancomycin and Imipenem-Cilastatin/Relebactam or Piperacillin/Tazobactam in a Preclinical Model. Antimicrobial agents and chemotherapy, 2021, 03-18, Volume: 65, Issue:4 Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Cilastatin, Imipenem Drug Combination; Drug Therapy, Combination; Male; Mice; Mice, Inbred C57BL; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin	2021

Article

Year

Alteration in Acute Kidney Injury Potential with the Combination of Vancomycin and Imipenem-Cilastatin/Relebactam or Piperacillin/Tazobactam in a Preclinical Model.

Antimicrobial agents and chemotherapy, 2021, 03-18, Volume: 65, Issue:4

Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Azabicyclo Compounds; Cilastatin, Imipenem Drug Combination; Drug Therapy, Combination; Male; Mice; Mice, Inbred C57BL; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin

2021